{"name":"Novelwise Pharmaceutical Corporation","slug":"novelwise-pharmaceutical-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQXzNLX0IwdWhXZGY1OVBWemgtRHZ5bkVHdVJUNWRQX2wyN2xxNjR6ZXlPSnNmZjFVa1ozQlQ3dTNkZEJSOWRFWEFJcEtXejUxREZkSHRYUWxpUFVTckM0cUVzUHc5MEstYXlmREN0Z29tMzhRejAyWmhzMVZGSjlnWTlYYUE4amZKT0k0aUJ2MnZENER2RGZrMS12MUVtTkE?oc=5","date":"2026-03-17","type":"trial","source":"openPR.com","summary":"HDAC inhibitors Clinical Trial Pipeline Appears Robust With 40+ - openPR.com","headline":"HDAC inhibitors Clinical Trial Pipeline Appears Robust With 40+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQX3duZHppU29ERFBHeXNUamY3VkVNc0FFZXNnNVlLbWZNQ2I2UmVrNlBEVjVwTGNydFFrZmZpR3NaSENXWGR1T2NnOW9tcjAwTVhMQllfb0xQbFNoNHFDV1ZhNWdFOHBjYVRpeVJOT3kwZ1RyQjBJR2VVQ3VCN09CeWhhb3pZTzJvZnRSMTlGWVZTUQ?oc=5","date":"2025-11-25","type":"regulatory","source":"Targeted Oncology","summary":"NBM-BMX Earns FDA Orphan Drug Status for Uveal Melanoma - Targeted Oncology","headline":"NBM-BMX Earns FDA Orphan Drug Status for Uveal Melanoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQQWF4bjBGZURZNXMyM2dVMGl2eURNclVlcUFjbFpxXy1TLV9mb0Myc1lhTFlUVG9lSm1YaEd5bkFSN3dReGtLRkFGaHdWQ3EtQWNYTzJOTnNOSFlSTVE2UVF4LXNab0s2V1ZtVzl4WHBpN2ctY0lQVGhBQUFCb1JtM1IySjFmaDlLQ2ZCYVhfQms5RTIzVXo2RXA4R2plVF9mYlBF?oc=5","date":"2025-11-04","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in October 2025 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in October 2025","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}